2,3,5,6-Tetramethoxyphenethylamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2,3,5,6-Tetramethoxyphenethylamine (2,3,5,6-TeMPEA), also known as TeMPEA-3, is a drug of the phenethylamine family related to the psychedelic drug mescaline (3,4,5-trimethoxyphenethylamine).[1] It is one of the possible positional isomers of tetramethoxyphenethylamine (TeMPEA).[1]
| Clinical data | |
|---|---|
| Other names | 2,3,5,6-TeMPEA; TeMPEA-3 |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C12H19NO4 |
| Molar mass | 241.287 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
The in-vitro metabolism and effects of TeMPEA-3 on behavior in animals have been studied.[1][2][3] Unlike mescaline, TeMPEA-3 was inactive in the conditioned avoidance response test in rats.[1][4] The effects of TeMPEA-3 in humans have not been reported and are unknown.[1]
The drug was first described in the scientific literature by 1955.[1][5] TeMPEA-3 was included as an entry in Alexander Shulgin's 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[6]
See also
- Substituted methoxyphenethylamine
- Tetramethoxyphenethylamine (TeMPEA)
- 2,3,4,5-Tetramethoxyphenethylamine (TeMPEA, TeMPEA-1)
- 2,3,4,6-Tetramethoxyphenethylamine (TeMPEA-2)
- 2,3,5,6-Tetramethoxyamphetamine (TeMA-3)
- Pentamethoxyphenethylamine (PeMPEA)
- Trimethoxyphenethylamine (TMPEA)